Cas:607737-87-1 A 77-01 manufacturer & supplier

Chemical Name:A 77-01

CAS.NO:607737-87-1

Synonyms:4-[3-(6-Methyl-2-pyridinyl)-1H-pyrazol-4-yl]-quinolone;A 77-01

Molecular Formula:C₁₈H₁₄N₄

Molecular Weight:286.33100

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:481.63ºC at 760 mmHg

Density:1.254g/cm3

Index of Refraction:1.685

PSA:54.46000

Exact Mass:286.12200

LogP:3.99530

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-[3-(6-Methyl-2-pyridinyl)-1H-pyrazol-4-yl]-quinolone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,A 77-01 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,A 77-01 Use and application,4-[3-(6-Methyl-2-pyridinyl)-1H-pyrazol-4-yl]-quinolone technical grade,usp/ep/jp grade.

Related News: Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities. A 77-01 manufacturer In approving the first new Alzheimer’s drug in nearly 20 years, the U.S. Food and Drug Administration is taking its biggest risk yet with a strategy that allows new therapies onto the market without strong evidence that they work, regulatory and scientific experts say. A 77-01 supplier The two trials studied similar patient populations, Tendler said, but VMP was an old standard of care that’s not really used today in the U.S. Still, Tendler believes the two regimens may both have roles to play based on each patient’s ability to tolerate them. Whichever cocktail physicians choose, the two phase 3 studies have confirmed the benefit of Darzalex in transplant-ineligible patients, he added. A 77-01 vendor Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities. A 77-01 factory In approving the first new Alzheimer’s drug in nearly 20 years, the U.S. Food and Drug Administration is taking its biggest risk yet with a strategy that allows new therapies onto the market without strong evidence that they work, regulatory and scientific experts say.